Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Exercise or conversion Director acquired 15,282 shares (option exercise)
  2. 4 Grant or award Chief Commercial Officer acquired 30,000 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Grant or award Chief Financial Officer acquired 187,500 shares (grant or award)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Shares withheld for taxes Director gave up 43,590 shares (to pay taxes)
  7. 4 Grant or award Director acquired 6,623 shares (grant or award)
  8. 4 Grant or award Director acquired 6,623 shares (grant or award)
  9. 4 Grant or award Director acquired 6,623 shares (grant or award)
  10. 4 Grant or award Director acquired 6,623 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 5 Insider Annual Insider Trading Report
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Grant or award Director acquired 8,947 shares (grant or award)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award Director acquired 40,198 shares (grant or award)
  18. 4 Grant or award Director acquired 6,865 shares (grant or award)
  19. 4 Grant or award Director acquired 6,865 shares (grant or award)
  20. 4 Grant or award Director acquired 6,865 shares (grant or award)

Page 12 of 15 · 296 filings